AIDS Treatment News
Table of Contents, July 25, 2003

• Failure of Combination Abacavir + Tenofovir + Lamivudine (3TC)
  An antiretroviral combination worked much less well than expected in controlling HIV. Patients using all three of these drugs together should talk with their doctor and consider changing treatment.

• FTC (Emtriva) Approved
  A new antiretroviral was approved July 2 -- the 19th now approved in the U.S. It is chemically related to 3TC.

• New HIV Treatment Guidelines Give More Advice
  New U.S. treatment guidelines give doctors and patients more guidance -- especially on what antiretrovirals to start with. Advice on when to start has not changed. While the new guidelines are more useful than previous editions, it remains critically important to have a physician with extensive experience in treating HIV.
  Advertisement

• HIV Drugs Approved as of August 2003
  Here is a list of the 19 antiretrovirals currently approved in the U.S., listed alphabetically by generic name within each of the four drug classes. Brand names and other common names are also included.

• Major HIV Treatment Conference in Paris -- Finding Reports Online
  Several Web sites have excellent coverage of the 2nd IAS (International AIDS Society) Conference on HIV Pathogenesis and Treatment, July 13-16 in Paris. Usually readers can look through a list of titles and click to read the reports important to them. We also comment on how software advances could greatly improve medical conferences over the next several years.

• Nelson Mandela on Treatment Access
  "If we discard the people who are dying from AIDS, then we can no longer call ourselves decent people."

ISSN # 1052-4207

Copyright 2003 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.